• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Permira in USD 5.8bn Mimecast take-private

  • Harriet Matthews
  • Harriet Matthews
  • 08 December 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Permira is to acquire UK-headquartered cybersecurity software Mimecast in a USD 5.8bn take-private deal, the company announced in a statement on 7 December.

The announcement follows a process in which Mimecast conducted discussions with several potential strategic and financial investors. The offer has been approved and recommended by Mimecast's independent special committee and its board of directors.

The offer is priced at USD 80 per ordinary share and will see Permira acquire all outstanding ordinary shares in the company, according to a statement.

Mimecast

  • DEAL:

    Buyout

  • VALUE:

    USD 5.8bn

  • LOCATION:

    London

  • SECTOR:

    Software

  • FOUNDED:

    2003

  • TURNOVER:

    USD 501.4m (2020)

  • EBITDA:

    USD 127.2m (2020)

The offer also includes a 30-day "go-shop" period, which expires on 6 January 2022, according to a statement. During this period, Mimecast's special committee and its advisers will initiate, solicit, encourage and evaluate alternative acquisition proposals, and could enter into negotiations with any parties that may offer alternative acquisition proposals.

Permira is investing via Permira VII, which held a final close in October 2019 on EUR 11bn, deploying equity tickets of EUR 250m-1bn and targeting businesses with enterprise values of EUR 500m-3bn. The GP registered the next fund in its flagship strategy in July 2021, as reported.

Blackstone and Ares are providing debt to back the deal, according to a statement.

Permira's previous investments in workplace software include TeamViewer; the GP sold shares worth USD 1.1bn in the remote IT support software in May 2020, having acquired the Germany-based company in 2014 before listing it in an IPO in September 2019. The GP also participated in a consortium to acquire US-headquartered McAfee in November 2021.

Taking into account the PE-backed take-privates of Mimecast, pharmaceuticals company Clinigen and supermarket chain Morrisons, the UK market will have seen announced de-listings worth more than GBP 14.6bn in 2021, according to Unquote Data. The aggregate value for 2021 is set to be the second highest recorded in the past 10 years, surpassed only by 2019, which saw large-cap deals including Advent's GBP 4.14bn acquisition of Cobham, as well as Blackstone and Canada Pension Plan Investment Board's (CPPIB) GBP 5.9bn acquisition of Merlin Entertainments.

Previous funding
In 2008, Dawn Capital provided capital of around EUR 6m for Mimecast.

In 2010, Index Ventures and Dawn invested GBP 13m in the company via a Series-B round.

Insight Partners led a USD 62m funding round for Mimecast in 2012.

Mimecast listed on the Nasdaq with a market capitalisation of USD 78m in 2015. The company posted revenues of USD 116m in the financial year ending in March 2015.

Company
Founded in 2003, Mimecast is a cybersecurity software platform for businesses. Its products include email security, cybersecurity awareness training and web security. The company is headquartered in London, but is domiciled in Jersey.

Mimecast posted adjusted EBITDA of USD 127.2m in 2021 with an EBITDA margin of 25.4%, alongside revenues of USD 501.4m, compared with revenues of USD 427m in 2020.

People
Mimecast – Peter Bauer (chairman, CEO); Robert Schechter (independent director).
Permira – Michail Zekkos, Ryan Lanpher (partners); Pierre Pozzo (principal).

Advisers
Vendor – Citi (corporate finance); Goodwin Procter (legal).
Equity – Qatalyst Partners (corporate finance); Bank of America Securities (corporate finance); JP Morgan (corporate finance); RBC Capital Markets (corporate finance); Fried Frank Harris Shriver & Jacobson (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • UK / Ireland
  • Technology
  • Take Private
  • Permira
  • United Kingdom

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013